Evirgen, S. Et Al. 2023. Is the Y90-radioembolization treatment effective on the intermediate-advanced stage of hepatocellular carcinoma and what is the albumin-bilirubin score’s prediction factor for survival?. Hepatology Forum , vol.4, no.3 , 103-107.

Evirgen, S., ÇAVUŞ, B., Gokturk, S., Iliaz, R., ÖZKAN, Z. G., Baran, B., ... ÇİFCİBAŞI ÖRMECİ, A.(2023). Is the Y90-radioembolization treatment effective on the intermediate-advanced stage of hepatocellular carcinoma and what is the albumin-bilirubin score’s prediction factor for survival?. Hepatology Forum , vol.4, no.3, 103-107.

Evirgen, Sami Et Al. "Is the Y90-radioembolization treatment effective on the intermediate-advanced stage of hepatocellular carcinoma and what is the albumin-bilirubin score’s prediction factor for survival?," Hepatology Forum , vol.4, no.3, 103-107, 2023

Evirgen, Sami Et Al. "Is the Y90-radioembolization treatment effective on the intermediate-advanced stage of hepatocellular carcinoma and what is the albumin-bilirubin score’s prediction factor for survival?." Hepatology Forum , vol.4, no.3, pp.103-107, 2023

Evirgen, S. Et Al. (2023) . "Is the Y90-radioembolization treatment effective on the intermediate-advanced stage of hepatocellular carcinoma and what is the albumin-bilirubin score’s prediction factor for survival?." Hepatology Forum , vol.4, no.3, pp.103-107.

@article{article, author={Sami EVİRGEN Et Al. }, title={Is the Y90-radioembolization treatment effective on the intermediate-advanced stage of hepatocellular carcinoma and what is the albumin-bilirubin score’s prediction factor for survival?}, journal={Hepatology Forum}, year=2023, pages={103-107} }